TradingAgents AISign inGet started
All stock profiles
TLRYNASDAQHealthcare

TILRAY BRANDS INC

Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.

Latest price

$2.53

-4.17%

Alpha Vantage · 10/30/2026

Industry: Drug Manufacturers - Specialty & GenericCategory: Domestic Common StockCurrency: USDNews: 0 recent
Analyze TLRY free

One-year price history

Adjusted daily closes · 252 observations · as of Oct 30, 2026

Historical data, not a forecast

1 month

-29.1%

3 months

-45.5%

6 months

-58.9%

1 year

-80.4%

Year to date

-72.0%

52-week range

$2.53 – $13.94

Fundamental snapshot

Latest reported period: Aug 31, 2026

Sharadar reported data

Market cap

$373.9M

P/E

-2.3

P/B

0.2

P/S

0.4

Revenue

$963.1M

Net income

-$164.22M

Diluted EPS

-1.41

Gross margin

29.10%

Net margin

-17.10%

Return on equity

-10.30%

Total debt

$371.93M

Cash

$218.34M

Free cash flow

-$115.5M

Latest eight reported quarters

Reported quarterly values, newest first

PeriodRevenueNet incomeGross marginNet marginFree cash flow
Aug 31, 2026$257.15M-$43.14M30.10%-16.80%-$27.45M
May 31, 2026$281.71M-$49.57M32.10%-17.60%-$45.76M
Feb 28, 2026$206.73M-$26.57M26.60%-12.90%-$24.19M
Nov 30, 2025$217.51M-$44.93M26.40%-20.70%-$18.1M
Aug 31, 2025$209.5M-$322K27.40%-0.20%-$10.57M
May 31, 2025$224.54M-$1.27B30.10%-566.90%-$13.15M
Feb 28, 2025$185.78M-$789.44M28.00%-424.90%-$19.97M
Nov 30, 2024$210.95M-$85.34M29.00%-40.50%-$45.56M

Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.

Recent TLRY news

All market news

No ticker-linked stories are in the current archive.